Our laboratory has previously established an efficient and specific gene editing approach to correct fibroblasts and CD34+ cells from FA-A patients by harnessing the homology directed repair (HDR) pathway to integrate a therapeutic cassette into the human AAVS1 safe harbor locus of these cells25,26. The gene discussed is CD34; the disease is Friedreich ataxia.